Driven by its mission to develop drugs with superior safety and efficacy, Neuro Biomed  Corp. uses advanced methods of drug design, drug delivery technology and screening tools to invent new and to improve existing therapeutic compounds for treatment of neurological disorders.

Neuro Biomed's proprietary technologies have resulted in products that have increased efficacy and/or reduced side effects relative to their precursors and to competing products.

 

Neuro Biomed's Drug Delivery Technology develops innovative pharmaceutical products which utilize proprietary delivery technologies to control the release of the active substance. The company has developed novel drug delivery technologies which are designed to release drugs over periods ranging from 24 hours to several months.

Drug Delivery Technology is the application of biochemical engineering to solve the problems required to most efficiently and safely deliver an active pharmaceutical agent to the target site where it can effectively exert the desired therapeutic action. 

Our Drug Delivery Technology Group focuses on the design, development and formulation of an acceptable dosage form and optimal dosage regime for neurological application. Neuro Biomed' Drug Delivery Systems are applicable to a wide range of therapies and routes of administration including parenteral, oral, topical, vaginal and rectal. Drug Delivery System can be employed prospectively to more efficiently deliver new chemical entities and used retrospectively to optimize the delivery systems of approved drugs.

Effective use of drug delivery technologies benefits both the patient and the developer of the product, the pharmaceutical or biotechnology company. 

Prior to launch, a new chemical entity or a biological product passes through a number of different stages—from discovery through Phase III—before it reaches the marketplace. Drug delivery technologies can now be applied at any stage during the early research and development of a new drug, to optimize the formulation and presentation of the drug.

Marketed products may also benefit from the application of drug delivery technologies. Drug delivery technologies can be employed after approval to improve the performance characteristics of a marketed product.

These technologies are combined with new or existing active substances to create pharmaceutical products targeted at market sectors where there are opportunities to enhance therapy, reduce side effects and improve compliance. 

NanoBio Drug Delivery System™

Our patented NanoBio Drug Delivery System™ is based on the advanced development of the novel nanostructure bio-electric membrane for drug delivery and diagnostic applications.

• NanoBio Membrane 's™ properties make it an ideal drug delivery platform, with high efficiency/capacity of drug loading-up to 97%

• safe biodegradable product 

• Ensure aseptic system with built-in nanoscale membrane (50 nanometers) eliminating particulates, bacteria, and endotoxin.

• Heat and radiation stable for ease of gamma radiation

• NanoBio Membrane is suitable for most injectable formulations

• Nanoscale pore size and Bio-electric charges can be controlled to accommodate different drug release pharmacokinetics (over hours/days/weeks and months)
  
   
   

• Bio-electric charges of the membrane enable interface with microelectronic processor for precise programmable controlled delivery

• Self-regulating delivery system with built-in microchip for ‘smart' monitoring and diagnostic applications.

For further information, please contact our Clinical Research Manager at research@neurobiomed.com